SER vs VICI · rev $56.0K vs P/E 9.3, rev $3.85B
Serina Therapeutics Inc (SER) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
SER currently screens at market cap $29.7M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the SER and VICI stock pages for the full models.
Not investment advice.